+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Women's Health Diagnostics Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

  • ID: 4829897
  • Report
  • Region: Global
  • 141 pages
  • 360iResearch
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere Inc.
  • Biomérieux SA
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Hologic, Inc.
  • MORE
The Global Women's Health Diagnostics Market is expected to grow from USD 29563.84 Millions in 2018 to USD 52536.84 Millions by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.56%.

Increasing instances of chronic and life style- related disorders in women is one of the factors largely attributing to the growth of the Global Women's Health Diagnostics Market

The factors attributing to the growth of the market are Availability of imaging and private diagnostic centres, Awareness about fertility testing in women coupled with initiatives taken by health organizations and government, PPP to develop the modern infrastructure of diagnostic imaging centres, Increasing instances of chronic and life style- related disorders in women, and Adoption of point-of-care and rapid diagnostic tests. However, some factors such as Limited technically skilled lab assistants may hinder the market growth. The Global Women's Health Diagnostics Market is expected to showcase the opportunities such as Growing focus on microfluidics and nanotechnology-based POC devices for diagnostic, Improved and technically advanced healthcare infrastructure in emerging economies, Regulatory approvals for immunoassay diagnostics techniques, and Clinical trial assessment for the diagnosis of breast cancer. In the near future market may face the possible challenges in the growth due to High cost associated with procedures and diagnostic imaging systems and Stringent regulatory guidelines. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the Global Women's Health Diagnostics Market.

On the basis of Application, the Global Women's Health Diagnostics Market is studied across Breast Cancer Testing, Cervical Cancer Testing, Infectious Disease Testing, Osteoporosis Testing, Ovarian Cancer Testing, Pregnancy and Fertility Testing, Prenatal Genetic Screening and Carrier Testing, Sexually Transmitted Disease Testing, and Ultrasound Tests.

On the basis of End User, the Global Women's Health Diagnostics Market is studied across Diagnostic and Imaging Centers, Home Care, and Hospitals and Clinics.

Perkinelmer Inc. the potential growing player for the Global Women's Health Diagnostics Market

The key players profiled in the Global Women's Health Diagnostics Market are Perkinelmer Inc., Abbott Laboratories, Quest Diagnostics Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Alere Inc., Hologic, Inc., Siemens AG, GE Healthcare, Biomérieux SA, and Koninklijke Philips N.V..

The report covers two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.

Research Methodology:

The market forecasting is based on a market model
derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Women's Health Diagnostics Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Women's Health Diagnostics Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Women's Health Diagnostics Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Women's Health Diagnostics Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Women's Health Diagnostics Market

The report answers questions such as:

1. What is the market size of Women's Health Diagnostics market in the Global?
2. What are the factors that affect the growth in the Global Women's Health Diagnostics Market over the forecast period?
3. What is the competitive position in the Global Women's Health Diagnostics Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Women's Health Diagnostics Market?
5. What are the opportunities in the Global Women's Health Diagnostics Market?
6. What are the modes of entering the Global Women's Health Diagnostics Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere Inc.
  • Biomérieux SA
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Hologic, Inc.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. FPNV Positioning Matrix
2.3.2.1. Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support

3. Executive Summary
3.1. Outlook in the Women’s Health Diagnostics Market
3.2. Opportunities in the Women’s Health Diagnostics Market
3.3. Geographical Analysis in the Women’s Health Diagnostics Market

4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing instances of chronic and life style- related disorders in women
4.2.1.2. Awareness about fertility testing in women coupled with initiatives taken by health organizations and government
4.2.1.3. Adoption of point-of-care and rapid diagnostic tests
4.2.1.4. Availability of imaging and private diagnostic centres
4.2.1.5. PPP to develop the modern infrastructure of diagnostic imaging centres
4.2.2. Restraints
4.2.2.1. Limited technically skilled lab assistants
4.2.3. Opportunities
4.2.3.1. Improved and technically advanced healthcare infrastructure in emerging economies
4.2.3.2. Regulatory approvals for immunoassay diagnostics techniques
4.2.3.3. Growing focus on microfluidics and nanotechnology-based POC devices for diagnostic
4.2.3.4. Clinical trial assessment for the diagnosis of breast cancer
4.2.4. Challenges
4.2.4.1. High cost associated with procedures and diagnostic imaging systems
4.2.4.2. Stringent regulatory guidelines
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends

5. Global Women’s Health Diagnostics Market, by Application
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Breast Cancer Testing
5.3.1. Biopsies
5.3.2. Blood Chemistries and Blood Cell Count Tests
5.3.3. Breast Cancer Tumor Marker Tests
5.3.4. Mammography
5.4. Cervical Cancer Testing
5.4.1. HPV Testing
5.4.2. PAP Smear
5.5. Infectious Disease Testing
5.5.1. HEPAtitis Testing
5.5.2. MRSA Testing
5.5.3. Tuberculosis Testing
5.5.4. Urinary Tract Infection Testing (Vaginal Ph & Vaginitis)
5.6. Osteoporosis Testing
5.6.1. Bone Densitometry
5.6.2. in Vitro Blood Tests
5.7. Ovarian Cancer Testing
5.7.1. Diagnostic Imaging Tests
5.7.2. Ovarian Cancer Tumor Marker Tests
5.8. Pregnancy and Fertility Testing
5.8.1. Fertility Monitors
5.8.2. Lab-Based Testing
5.8.3. Pregnancy Testing and Ovulation Prediction Kits
5.9. Prenatal Genetic Screening and Carrier Testing
5.9.1. Cystic Fibrosis
5.9.2. Down Syndrome and Edwards Syndrome
5.9.3. Torch Infections
5.10. Sexually Transmitted Disease Testing
5.10.1. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG) Testing
5.10.2. HIV Testing
5.11. Ultrasound Tests
5.11.1. Breast Imaging
5.11.2. OB/GYN Imaging

6. Global Women’s Health Diagnostics Market, by End User
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Diagnostic and Imaging Centers
6.4. Home Care
6.5. Hospitals and Clinics

7. Americas Women’s Health Diagnostics Market Estimates & Trend Analysis
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Canada
7.4. Mexico
7.5. United States

8. Asia-Pacific Women’s Health Diagnostics Market Estimates & Trend Analysis
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. China
8.4. India
8.5. Japan

9. Europe, Middle East & Africa Women’s Health Diagnostics Market Estimates & Trend Analysis
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. France
9.4. Germany
9.5. United Kingdom

10. Competitive Landscape
10.1. FPNV Positioning Matrix for Global Women’s Health Diagnostics Market
10.2. Market Vendor Ranking Analysis for Global Women’s Health Diagnostics Market
10.3. Competitive News Feed Analysis for Global Women’s Health Diagnostics Market
10.3.1. Mergers & Acquisitions
10.3.2. New Product Launches
10.3.3. Business Expansions
10.3.4. Partnerships, Agreements & Collaborations

11. Company Usability Profiles
11.1. F. Hoffmann-La Roche AG
11.1.1. Overview
11.1.2. Strategy
11.1.3. SWOT
11.1.4. Scorecard
11.2. Hologic, Inc.
11.2.1. Overview
11.2.2. Strategy
11.2.3. SWOT
11.2.4. Scorecard
11.3. Perkinelmer Inc.
11.3.1. Overview
11.3.2. Strategy
11.3.3. SWOT
11.3.4. Scorecard
11.4. Quest Diagnostics Inc.
11.4.1. Overview
11.4.2. Strategy
11.4.3. SWOT
11.4.4. Scorecard
11.5. Siemens AG
11.5.1. Overview
11.5.2. Strategy
11.5.3. SWOT
11.5.4. Scorecard
11.6. Abbott Laboratories
11.6.1. Overview
11.6.2. Strategy
11.6.3. SWOT
11.6.4. Scorecard
11.7. Alere Inc.
11.7.1. Overview
11.7.2. Strategy
11.7.3. SWOT
11.7.4. Scorecard
11.8. Becton, Dickinson and Company
11.8.1. Overview
11.8.2. Strategy
11.8.3. SWOT
11.8.4. Scorecard
11.9. Biomérieux SA
11.9.1. Overview
11.9.2. Strategy
11.9.3. SWOT
11.9.4. Scorecard
11.10. GE Healthcare
11.10.1. Overview
11.10.2. Strategy
11.10.3. SWOT
11.10.4. Scorecard
11.11. Koninklijke Philips N.V.
11.11.1. Overview
11.11.2. Strategy
11.11.3. SWOT
11.11.4. Scorecard

12. Appendix
12.1. Discussion Guide
12.2. Top Reports
12.2.1. Global Gastrointestinal Drugs Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.2. Global Polymer Matrix Composites Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.3. Global Policy Management Software Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.4. Global Smart Waste Management Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.3. Author Details
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Perkinelmer Inc.
  • Quest Diagnostics Inc.
  • Siemens AG
  • Abbott Laboratories
  • Alere Inc.
  • Becton, Dickinson and Company
  • Biomérieux SA
  • GE Healthcare
  • Koninklijke Philips N.V.
Note: Product cover images may vary from those shown
Adroll
adroll